What is the recommended dosing for Chymoral forte (alpha-chymotrypsin) tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Chymoral Forte Tablets

The recommended dosing for Chymoral Forte (alpha-chymotrypsin) tablets is 6 drops orally 4 times a day for patients aged 2 years to adult. 1

Dosage Information

Chymoral Forte is an enzymatic preparation containing alpha-chymotrypsin, which has anti-inflammatory properties. The FDA-approved labeling provides clear guidance on the appropriate dosing:

  • Standard dosage: 6 drops orally 4 times daily
  • Age range: Suitable for patients from 2 years of age through adulthood
  • Administration: Should be taken orally

Clinical Applications

Chymoral Forte has been studied in various clinical scenarios:

  • Burn patients: Research has shown that Chymoral Forte can modulate cytokine levels (IL-6 and IL-1beta) in burn patients, potentially regulating the severity of the inflammatory phase 2
  • Musculoskeletal conditions: Some evidence suggests potential benefit in inflammatory conditions, though clinical significance may be limited 3
  • Acute-phase protein modulation: The preparation has demonstrated effects on acute-phase proteins following burn injury, reflecting potential anti-inflammatory activity 4

Important Considerations

When prescribing Chymoral Forte, clinicians should be aware of:

  • Limited robust evidence: While the medication has an established dosing protocol, high-quality evidence for efficacy in many conditions is limited
  • Primary mechanism: Works through proteolytic enzyme activity to potentially reduce inflammation
  • Monitoring: No specific monitoring parameters are required, but clinical response should be assessed

Potential Pitfalls

  • Overestimating efficacy: One study examining Chymoral in lumbar disc prolapse found its value to be "little better than placebo" despite some improvements in straight-leg raising and reduced analgesic requirements 3
  • Drug interactions: As with any proteolytic enzyme, potential interactions with anticoagulants or antiplatelet medications should be considered, though specific data for Chymoral Forte is limited
  • Expecting immediate results: The anti-inflammatory effects may take time to develop, as suggested by studies showing changes in inflammatory markers over several days 4

While Chymoral Forte has been studied in specific clinical scenarios like burn management, clinicians should maintain realistic expectations about its efficacy and follow the recommended dosing of 6 drops orally 4 times daily.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.